Paul McGarty joins Lupin Pharmaceuticals
This article was originally published in Scrip
Executive Summary
Lupin has appointed Paul McGarty president of its US subsidiary, Lupin Pharmaceuticals. He has more than 25 years' experience in the pharmaceutical industry, having most recently served as CEO of Nycomed US.